4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000057
President, Research & Develop. sold 600 shares at $18.00 ($10,800)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan President, Research & Develop. | 2024-10-16 | Sale 10b5-1 | −600 | $18.00 | $10,800 | 183,216 | D: show line 1 in the form |
| Open-market sales · 600 sh · avg $18.00 · $10,800 | |||||||
Loading xslF345X05/wk-form4_1729283492.xml…